EBJIS 2025
SPONSORSHIP & EXHIBITION
Ethical Medtech
We are happy to announce that EBJIS 2023 is compliant with the Eucomed Code of Ethical Business Practice.
For more information please see www.ethicalmedtech.eu
Thank you to our confirmed sponsors
Platinum Sponsors
At Biocomposites, we are distinct in that our team of specialists is singularly focused on the development of innovative calcium compounds for surgical use.
With over 30 years’ experience and an unrivalled dedication to quality, the products we research, engineer and manufacture are at the forefront of calcium technology.
We are proud to be driving improved outcomes across a wide range of clinical applications, in musculoskeletal infection, trauma, spine and sports injuries, for surgeons and patients alike.
Visit www.biocomposites.com for more information.
BONESUPPORT™ sells CERAMENT, synthetic bone substitutes that promote and protect bone healing. There are three CERAMENT products; CERAMENT BONE VOID FILLER, CERAMENT G with gentamicin and CERAMENT V with vancomycin. All three products remodel into bone within 6-12 months, and CERAMENT G and V also elute either gentamicin or vancomycin to provide a high local concentration of antibiotic that protects bone healing. Our products are used when bone defects cannot heal by themselves, for example in trauma, fracture-related infection, chronic osteomyelitis and diabetic foot osteomyelitis.
Visit www.bonesupport.com for more information.
Heraeus Medical stands for delivering value to the patient, the healthcare professional and the healthcare system through innovation and evidence based medicine in Implant Fixation, Infection Management and regenerative treatments for bone, cartilage and soft tissue. Over the years the company built up extensive experience in the field of therapeutic support for PJI with local antibiotics and is a reliable and committed partner in all aspects that deal with the management of musculoskeletal infections.
Visit www.heraeus.com for more information.
Gold Sponsors
A world leader in in vitro diagnostics for 60 years, bioMérieux provides solutions that determine the origin of a disease. World leader in microbiology, specialized in immunoassays, and leading pioneer in the syndromic molecular approach, the Company is committed on major public health issues, such as antimicrobial resistance, sepsis, and respiratory infections.
Our BioFire® Joint Infection Panel detects multiple bacteria, fungi, and antimicrobial resistance genes directly from a single patient sample with results available in about 1 hour.
Please visit www.biomerieux.com for more information.
InfectoPharm is a family-owned company located in Germany. With IV FOSFOMYCIN (product names Fomicyt®, InfectoFos® and Fosfomycin InfectoPharm), InfectoPharm offers a therapeutic option to fight severe infections in a broad indication spectrum. It is an antibiotic of it´s own class with unique product characteristics: unique mode of action, a tissue penetration champion, capable of penetrating tissue with poor accessibility with high bactericidal levels with broad spectrum against Gram positive and – negative pathogens including MDR bacteria.
Visit en.infectopharm.com for more information.
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.
With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.
For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.eu or follow Zimmer Biomet on LinkedIn and on Twitter.
OSARTIS GmbH is a medical device company located in Germany focusing on the development, registration, production and distribution of medical biomaterials and PMMA bone cements.
Please visit https://osartis.de/en/ for more information.
Silver Sponsor
EUROPEAN CELL AND TISSUE BANK, a non-profit association, based in Austria. In compliance with the EU directives, we procure, store, processes and distribute tissue, and offer with OSmycin™, a human bone allograft, impregnated with antibiotics (Vancomycin or Tobramycin). OSmycin™ for simultaneously preventing infection and biofilm while reconstructing of bone defects.
Visit www.ectb.eu for more information.
Bronze Sponsor
At the intersection of technology and human biology, Bonalive® granules reduces the need for antibiotics in the resolution of chronic bone infections. Bonalive Biomaterials provides patients and surgeons with well-proven and safe bone regenerative products in orthopedics, trauma, spine and septic bone surgery. It’s time to heal smarter. #SmartHealing
Visit www.bonalive.com for more information.
G-21 is an innovator in the bone cement market for orthopedics and minimally invasive spine surgery bringing strenght to life for every patient.
Commitment, dedication and drive to find modern solutions combined with proprietary patents make the G-21 portfolio unique in the industry.
The entire product portfolio has been developed in-house and tested through research programs with renowned institutions and universities worldwide.
Located outside Modena, Italy, quality and manufacturing are critical to consistently delivering high-performing cement and accessories to the market in over 45 countries.
Visit www.g-21.it for more information
InBiome specializes in advanced molecular technology aimed at improving health and longevity. Our Molecular Culture® technology enables rapid and precise detection of bacteria in clinical samples, with assays that are CE/IVD marked. The technology not only identifies individual bacteria but also complex microbiotas at the species level. InBiome collaborates with universities and hospitals to advance bacterial diagnostics and preventive healthcare. Our main products include Molecular Culture® and Molecular Culture® Microbiota.
Please visit www.inbiome.com for more information.
Dedicated to PJI diagnostics, Lyfstone provides advanced, accurate, CE-IVD compliant rapid testing that enables healthcare professionals to improve patient outcomes.
Please visit www.lyfstone.com for more information.
MicroGenDX is the leader of microbial infection diagnostics through Next-Generation Sequencing (NGS), with more than 1,5 million patient samples processed, the most comprehensive bioinformatics pipeline and over 70 clinical studies published, of which 23 in orthopedics. Our highly sensitive, fast and affordable molecular diagnostics will be available in Europe soon.
Please visit www.microgendx.com for more information.
Molzym produces and markets high-quality products for the culture-independent molecular detection of pathogens. Products range from CE-IVD-marked diagnostic solutions, host DNA depletion kits (MolYsis™) to ultra-clean PCR assays.
Visit www.molzym.com for more information
OSARTIS GmbH is a medical device company located in Germany focusing on the development, registration, production and distribution of medical biomaterials and PMMA bone cements.
Please visit https://osartis.de/en/ for more information.
Pfizer’s mission and vision is better known as Pfizer’s purpose, which is Breakthroughs That Change Patients’ Lives. Pfizer culture is driven by four core values: courage, excellence, equity, and joy.
Please visit https://www.pfizer.com/ for more information.
RESORBA Medical GmbH is an Advanced Medical Solutions Group company.
Advanced Medical Solutions Group is a world-leading independent developer and manufacturer of innovative tissue healing technologies, focused on value for customers and quality outcomes for patients.
Our GENTA-COLL® resorb sponges combine the haemostatic properties of collagen with effective protection from the antibiotic gentamicin.
Visit www.resorba.com for more information.
For over 40 years Tecres has developed and manufactured PMMA bone cements for orthopaedics and devices for supporting the treatment of PJI. Cemex bone cements and Spacer, the unique temporary antibiotics-loaded prostheses for two-stage septic revision, are successfully sold worldwide. These products are available also in the combination Vancomycin-Gentamicin. We are active also in the field of spinal surgery and neurosurgery.
Please visit www.tecres.com for more information
Exhibitors
Collaborating Society
